La catena delle opzioni mostra i dati chiave delle opzioni azionarie di AllianceBernstein Holding a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per AllianceBernstein Holding..

AllianceBernstein Holding (NYSE:AB) Azioni, Catena delle Opzioni

AllianceBernstein Holding

AllianceBernstein provides investment management services to institutional (41% of assets under management), retail (41%), and private (18%) clients through products that includes mutual funds, hedge funds, and separately managed accounts. At the end of April 2025, the company had $781 billion in managed assets, composed primarily of fixed-income (38% of AUM) and equity (40%) strategies, with other investments (made up of asset allocation services and certain other alternative investments) accounting for the remainder.

Dividend Yield

News

Dividends

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

CSWC

Gli esperti segnalano 3 titoli che offrono rendimenti superiori alla media, ideali per gli investitori in cerca di reddito passivo.

3 azioni finanziarie con rendimenti da dividendo fino all&#39;11%

Rolling,Meadows,,Illinois,,Usa,-,March,27,,2022:,Gallaghers,Sign

Media

AMAT

FUBO

L&#39;analista della CNBC indica le società su cui puntare. I consigli per un portafoglio di investimenti solido.

Jim Cramer svela le sue scelte vincenti: ecco i titoli da non perdere

AllianceBernstein Holding LP

ABRDN ASIA-PAC INCOME FD by ABRDN ASIA-PAC INCOME FD

abrdn Asia-Pacific Income Fund VCC

AUTOMATIC BANK SERVICES by Automatic Bank Services Ltd.

Automated Bank Services Ltd

ALBA SE

American Battery Technology Company - Common Stock

American Battery Technology Co

A2B AUSTRALIA LTD by A2B Australia Ltd.

ABRDN ASIAN INCOME FUND by abrdn Asian Income Fund Limited

AUBURN BANCORP INC by Auburn Bancorp, Inc.

Auburn Bancorp Inc

ABBC Coin

ABB Ltd

Abrasilver Resource Corp

ABRASILVER RESOURCE CORP by AbraSilver Resource Corp

AbbVie Inc

Abby Inc

Athabasca Minerals Inc

Ameris Bancorp

ABC arbitrage SA

ABCO Energy Inc

ABACUS MINING & EXPL ORD by Abacus Mining & Exploration Corp.

Abacus Mining & Exploration Corp

ABACUS GROUP by ABACUS GROUP

AbCellera Biologics Inc

ABCAM PLC SPONSORED ADS

Ambase Corp

Alpha Blue Capital US Small-Mid Cap Dynamic ETF

ABCAM PLC ORD by Abcam PLC

Alm Brand AS

AB Dynamics PLC

AMBASSADOR FOOD SVCS CORP by Ambassador Food Services Corp.

ABINGDON HEALTH LTD by Abingdon Health Ltd.

Abingdon Health PLC

Abeona Therapeutics Inc

VISION LITHIUM INC by Vision Lithium Inc.

Vision Lithium Inc

Absolute Select Value ETF

Ambev S.A. American Depositary Shares (Each representing 1 Common Share)

Ambev SA

Abacus FCF Leaders ETF

ABERTIS INFRAESTRCTS ORD by Abertis Infraestructuras SA

ABERFORTH SM CO PLC by Aberforth Smaller Companies Trust PLC

Asbury Automotive Group Inc

Abengoa SA

ABG SUNDAL COLLIER ASA by ABG Sundal Collier ASA

ABG Sundal Collier Holding ASA

ALFEN BEHEER B V ADR by Alfen Beheer B.V.

Alfen NV

Argent Large Cap ETF

Ability Inc

ATHENA BITCOIN GLOBAL by ATHENA BITCOIN GLOBAL

Athena Bitcoin Global

AMER BASKETBALL ASSN INC by American Basketball Association, Inc.

Abacus Global Management, Inc. - Class A Common Stock

Abacus Global Management Inc

ABALANCE CORP by Abalance Corp.

Abacus FCF Real Assets Leaders ETF

ABLE ENERGY INC by Able Energy, Inc.

Abacus FCF International Leaders ETF

ALTEN BOULOGNE-BILLANCORT by Alten Boulogne-Billancourt

Alten

Abacus Global Management, Inc. - 9.875% Fixed Rate Senior Notes due 2028

Abacus FCF ETF Trust Abacus FCF Small Cap Leaders ETF

AMERICAN BILTRITE INC by American Biltrite, Inc.

American Biltrite Inc

Able View Global Inc. - Class B Ordinary Shares

Able View Global Inc

ABM Industries Inc

ALBIOMA by Albioma

ABCOURT MINES INC B by Abcourt Mines Inc.

Abcourt Mines Inc

AMER BIO MEDICA CORP by American Bio Medica Corp.

American Bio Medica Corp

Prodigy Gold NL

ABN AMRO Bank NV

ADVANCED BIOMEDICAL TECHS by Advanced BioMedical Technologies, Inc.

Advanced BioMedical Technologies Inc

Aben Minerals Ltd

Aben Gold Corp

Airbnb Inc

Tidal Trust II YieldMax ABNB Option Income Strategy ETF

ABOITIZ EQUITY VNTRS INC by Aboitiz Equity Ventures, Inc.

Aboitiz Equity Ventures Inc

Acumen Pharmaceuticals, Inc. - Common Stock

Acumen Pharmaceuticals Inc

Abacus FCF Innovation Leaders ETF

Abpro Holdings Inc

AIRBORNE SEC & PROT SVCS by Airborne Security & Protective Services, Inc.

Airborne Security & Protection Services Inc

AB INTL GROUP CORP NEW by AB INTL Group Corp.

AB International Group Corp

Arbor Realty Trust Inc

Arbor Metals Corp

Arbor Realty Trust 6.375% Series D Cumulative Redeemable Preferred Stock, Liquidation Preference $25.00 per Share

Arbor Realty Trust 6.25% Series E Cumulative Redeemable Preferred Stock

Arbor Realty Trust 6.25% Series F Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock, Liquidation Preference $25.00 per share

AB SCIENCE PARIS ORD by AB Science, Paris

AB Science

Absci Corp

ABACUS STORAGE KING by ABACUS STORAGE KING

ABS-CBN Holdings Corp Shs Philippine Depository Receipts Repr. 1 sh

ABS-CBN Holdings Corp

AIRBOSS OF AMERICA CORP by AirBoss of America Corp.

AirBoss of America Corp

Abbott Laboratories

Arcblock - United States Dollar

ALTEROLA BIOTECH INC by Alterola Biotech, Inc.

Alterola Biotech Inc

AB&T Financial Corp Com

Abits Group Inc

ABOITIZ EQTY VNT UNSP/ADR by Aboitiz Equity Ventures, Inc.

Arbutus Biopharma Corporation - Common Stock

Arbutus Biopharma Corp

ABVC BioPharma Inc

Above Food Ingredients Inc. - Common Stock

Above Food Ingredients Inc

AFFINITY BEVERAGE GROUP by Affinity Beverage Group, Inc.

Affinity Beverage Group Inc

Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) is trading at $2669, marking a <a href="https://www.benzinga.com/money/how-to-buy-ethereum">steady rise toward the $3000 mark</a>. The second-largest cryptocurrency by market cap has surged over 5% over the past week amid rising institutional interest, with BTCS boosting holdings, RWA tokenization on Ethereum Layer-2s, and a bullish price structure.
Blockchain company, BTCS Inc., has expanded its ETH holdings with a fresh purchase of 3450 ETH amounting to $8.43 million. The company's total Ethereum holdings are over 12,500 ETH, marking a 38% increase.
Don't Miss:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/go/plus-500-crypto-in-content">Trade crypto futures on Plus500 with up to $200 in bonuses</a> — no wallets, just price speculation and free paper trading to practice different strategies.</li>
<li>New to trading crypto?<a href="http://coinbase-consumer.sjv.io/m5ALXy"> Get up to $400 in rewards for successfully completing short educational courses and placing your first qualifying trade</a> on Coinbase.</li>
</ul>
CEO Charles Allen stated that Ethereum is central to BTCS's blockchain infrastructure approach. The company is enhancing the base needed to scale validator operations and boost staking income, while delivering sustained value to shareholders.&nbsp;
According to Cointelegraph, Real Vision founder, Raoul Pal, is pushing back at the skepticism surrounding Ethereum's future by calling it the "Microsoft of blockchain." He argued that traditional finance sees Ethereum as the clear base layer for tokenization, noting that firms such as JP Morgan Chase &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), and Goldman Sachs Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) are highly unlikely to build on Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>).&nbsp;
Analysts from AllianceBernstein Holding L.P. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AB#NYSE">AB</a>) echoed the sentiment, crediting Ethereum's price recovery to the growing recognition that traditional finance has already tokenized billions in US Treasuries and commodities.
Arthur Hayes, the co-founder of BitMEX, has doubled down on his forecast that Ethereum could reach its long-term target of $15,000. According to the Bankless Podcast, Arthur said a US $10,000 to US $15,000 price for ETH is far from unrealistic, citing a shift in the market sentiment.
"Everybody thought it was dead, but the most hated coin goes up fastest in the next cycle," he said. Hayes added that Ethereum's comeback is natural after being overshadowed by Solana, while pointing to the Pectra upgrade as a positive catalyst.
Buyers have remained active near the $2440 level, where ETH has formed a base for an upward move. ETH price broke past $2500 and $2520, crossing the 50% Fibonacci retracement of the drop from the $2615 high to the $2442 low.
A breakout above $2720 could push a rally toward $2840 and potentially $2920, or even $3000 in the short term. A failure to breach $2629 could trigger another dip, with the initial support at $2525 and major support at $2500.
With growing institutional backing, expanding layer 2 development, and bullish technicals, Ethereum is positioning itself for not just a break above $3000 but for a sustained rally that could redefine its position.
More Opportunities:
<ul class="wp-block-list">
<li>Grow your IRA or 401(k) with Crypto – <a href="https://info.irafinancial.com/lp/irafi-crypto/?utm_source=benzinga.com&amp;utm_medium=affiliate&amp;utm_campaign=y2">unlock the power of alternative investments including a Crypto IRA within your retirement account</a>.</li>
<li>Trade, earn, and grow your crypto portfolio with Crypto.com — <a href="https://www.benzinga.com/go/crypto-com-signup-bonus">plus receive up to $500 worth of rewards in the most popular tokens if you're a new customer</a>.</li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ETH

$SOL

Ethereum Hits $2669 Amid Institutional Flows, RWA Tokenization Fueling Bullish Breakout

In the current session, the stock is trading at $41.04, after a 0.54% increase. Over the past month, AllianceBernstein Holding Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AB#NYSE">AB</a>) stock increased by 12.80%, and in the past year, by 23.15%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1746194428_0_0.png" alt="Past Year Chart" />

<h3>AllianceBernstein Holding P/E Compared to Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 28.67 in the Capital Markets industry, AllianceBernstein Holding Inc. has a lower P/E ratio of 10.77. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1746194428_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Price Over Earnings Overview: AllianceBernstein Holding

Barclays analyst Benjamin Budish maintains AllianceBernstein Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AB#NYSE">AB</a>) with a Equal-Weight and raises the price target from $36 to $37.

Barclays Maintains Equal-Weight on AllianceBernstein Holding, Raises Price Target to $37

AllianceBernstein Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AB#NYSE">AB</a>) reported quarterly earnings of $0.80 per share which beat the analyst consensus estimate of $0.78 by 2.56 percent. This is a 9.59 percent increase over earnings of $0.73 per share from the same period last year. The company reported quarterly sales of $1.08 billion which beat the analyst consensus estimate of $852.93 million by 26.62 percent. This is a 2.17 percent decrease over sales of $1.10 billion the same period last year.

Comments

AllianceBernstein Holding

AllianceBernstein Holding (AB) Opzioni

AllianceBernstein Holding (NYSE:AB) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO